Understanding how healthcare access affects ovarian cancer outcomes
Official title: A Role of Multilevel Healthcare Access Dimensions in Ovarian Cancer Disparities
Funded at Duke University · NIH-10733044 · Data updated 2026-11-12
This study is looking at how different racial groups experience varying survival rates from ovarian cancer and how access to good healthcare plays a role, aiming to find out what barriers might be preventing fair treatment for all patients.
Quick facts
| Grant type | R37 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Duke University NIH-funded |
| Lab location | 1 site (Durham, United States) |
| Project start | August 1, 2024 |
| Project end | July 31, 2026 |
| Funding year | 2024 |
| Award (this year) | $526,625 |
| NIH project number | 4R37CA233777-07 |
| Project ID | NIH-10733044 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include ovarian cancer patients, especially those from non-Hispanic Black and other minority backgrounds who may face barriers to accessing quality care.
✕Less likely to help
Patients who are not diagnosed with ovarian cancer or those who have already received optimal treatment may not benefit from this research.
What this research studies
This research investigates the disparities in ovarian cancer survival rates among different racial groups, particularly focusing on how access to quality healthcare impacts these outcomes. It aims to analyze data from various healthcare access dimensions and their relationship with treatment adherence and survival rates. By examining the effects of structural racism and chronic stress on healthcare access, the study seeks to identify barriers that prevent equitable treatment for ovarian cancer patients. The research will utilize existing databases and longitudinal data to track healthcare access over time and its impact on patient outcomes.
Why it matters
Potential benefit: If successful, this research could lead to improved healthcare access and treatment strategies for ovarian cancer patients, particularly among underrepresented groups.
How similar studies have gone: Previous research has shown that addressing healthcare access disparities can lead to improved health outcomes, indicating that this approach has potential for success.
Where this research is happening
-
Duke University
Durham, United States Active
Researchers
- Principal investigator: Akinyemiju, Tomi F — Duke University
- Study coordinator: Akinyemiju, Tomi F
Related research
Other NIH-funded projects on the same topics.
-
Understanding the experience of ovarian cancer after diagnosis to improve survivorship
This NIH grant funds a mixed-methods study to better understand physical and emotional challenges faced by ovarian cancer survivors and how supportive care can help them live better after diagnosis.
-
Targeting quiescent ovarian cancer cells to overcome chemotherapy resistance
A study focusing on why some ovarian cancer cells pause dividing and resist chemotherapy, with the goal of finding new treatment targets for relapsed disease.
-
Photodynamic lipids to boost chemotherapy for metastatic ovarian cancer
A patient-friendly approach tests a light-activated method to make ovarian cancer metastases more sensitive to chemotherapy.
-
Integrated framework to validate and quantify proteoforms in patient-derived ovarian cancer cells
A collaboration will combine advanced top-down proteomics with a new computational method to precisely identify and measure intact proteoforms in tiny samples from ovarian cancer cells.
-
Overcoming platinum resistance in ovarian cancer: finding biomarkers and new targets
Researchers are looking for new biomarkers and targets to help prevent or overcome platinum resistance in high‑risk ovarian cancer so patients have better chances at long-term control.
-
Alternative NF-kB activation after chemotherapy in ovarian cancer
This grant studies how ovarian cancer might come back after chemotherapy by looking at specific signaling pathways in cancer cells and the tumor environment.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.